E-DRUG Archives (by thread)

Date Index

[e-drug] Conference: Risks of counterfeits in importation(2), Donald Light

[e-drug] RFI: Medicines for children under 5, Atieno Ojoo

[e-drug] RFI: Medicines for children under 5 (1), Essential Drugs Project

[e-drug] E-conference: Prescription Audit- A Case Study from India, reinhard huss

[e-drug] Cost effectiveness and cost benefit analysis (3), Kees de Joncheere

[e-drug] Cost effectiveness and cost benefit analysis (4), Akunne Anayo

[e-drug] Source of generic ivermectin?, Beverley Snell

[e-drug] Framework contracts for drug procurement, Rob Verhage

[e-drug] Framework contracts for drug procurement (2), AEDES-ZIM

[e-drug] UK Parliament: new critical report on pharm industry, Wilbert Bannenberg

[e-drug] New WHO Prequalification list for AIDS drugs, Carmen Perez

[e-drug] Source of generic ivermectin? (2), Atieno Ojoo

[e-drug] Source of generic ivermectin? (3), Horst Herb
- [e-drug] Handbook of drug discontinuation, Staffan Svensson

[e-drug] IDA Managing Drug Supply Course 29 May-11 June, Andrew Marshall

[e-drug] The Global Fund granting system is failing, Brook Baker

[e-drug] UK Govt on Good Pharmaceutical Industry practice, E-Drug

[e-drug] UK Parliament: new critical report on pharm industry (2), E-Drug

[e-drug] Source of generic ivermectin? (4), David Veazey / AFEW

[e-drug] Source of generic ivermectin? (5), Murtada Sesay

[e-drug] Draft Sri Lankan National Drug Policy for comments, E-Drug

[e-drug] Mefloquine as malaria chemoprophylaxis, kae

[e-drug] Mefloquine as malaria chemoprophylaxis (2), Andy Gray
[e-drug] Mefloquine as malaria chemoprophylaxis (3), Dr S Toovey

[e-drug] RFI: doxycycline agelimits and quinine malaria dosages, Kae

[e-drug] FDA action on Cox-2 NSAIDs; valdexocib withdrawal, E-Drug

[e-drug] RFI: Drug Revolving Fund Evaluation criteria, nilakantha bhoi

[e-drug] course: Management of Medicines in International Health, Tanja Schwering

[e-drug] Mefloquine as malaria chemoprophylaxis (4), Rina Meyer

[e-drug] Mefloquine as malaria chemoprophylaxis (5), Dr S Toovey

[e-drug] RFI: doxycycline agelimits and quinine malaria dosages (2), jude ike nwokike

[e-drug] Lancet article supports generic ARVs, E-Drug

[e-drug] Ivernmectin availability, James B. Russo

[e-drug] Lancet article supports generic ARVs (2), Norman Nyazema

[e-drug] HIVNET 012 Uganda nevirapine study validated by independent analysis, E-Drug

[e-drug] Pfizer fluconazole programme failing in Dominican Republic, Eugene Schiff

[e-drug] Malaria chemoprophylaxis (6), Bill Arnold

[e-drug] Training course: Supply Chain Management HIV/AIDS Medicines & Supplies, Clarisse Audrey Morris

[e-drug] Clinical Pearls from The Cochrane Library, Ciprian Jauca

[e-drug] MSF conference London 8 June innovation for neglected diseases, Mai Do

[e-drug] FDA warns against off-label use of antipsychotics in the elderly, E-Drug

[e-drug] UK: all Clinical Trials to be published before registration, E-Drug

[e-drug] EMEA warns against tenofovir-didanosine co-administration, E-Drug

[e-drug] More transparency about counterfeits needed, E-Drug

[e-drug] Institute for OneWorld Health receives grant for visceral leishmaniasis, Leela McCullough

[e-drug] USA trying to block abortion pills in new WHO EML?, E-Drug

[e-drug] USA trying to block abortion pills in new WHO EML? (2), Atieno Ojoo
[e-drug] USA trying to block abortion pills in new WHO EML? (3), Norman Lufesi

[e-drug] BMJ: Say no to the free lunch, E-Drug

[e-drug] WHO/EDM-UNICEF Technical Briefing Seminar September 2005, Laing, Richard

[e-drug] Employment opportunities with Axios Group, Joanna Ignaszewska

[e-drug] Economist: One World Health and neglected diseases, Libby Levison

[e-drug] Tinidazole versus Metronidazole for H pylori eradication, Olutayo Adetokunbo

[e-drug] Med-reps and irrational medicine use in sub-Saharan Africa, Olutayo Adetokunbo

[e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (2), Dr Peter R Mansfield
- [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa(3), Dardane Arifaj-Blumi

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare, Kibumba George

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare (2), Billy Futter

[e-drug] PEPFAR, Global Health Corps & brain drain, Libby Levison

[e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (4), sushobhit singh

[e-drug] WHO database of ARV registration in countries, Wilbert Bannenberg

[e-drug] antibiotics still a problem, P. Swarts

[e-drug] Antibiotics still a problem (2), Anibal Sosa, MD

[e-drug] Med-reps and irrational medicine use in sub-Saharan Africa(5), Atieno Ojoo

[e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (5), Kevin Outterson

[e-drug] Economist: Seeking a cure for legal headaches, E-DRUG

[e-drug] Global Fund changes quality assurance rules, E-Drug

[e-drug] RFI: STI clinic supply management, Carolyn Green

[e-drug] Gilead licenses Aspen Pharmacare To Produce ARVs, Leela McCullough

[e-drug] Send an abstract to the 20-22 June SEAM Conference in Accra!, Keith Johnson

[e-drug] Health Product Innovation in Developing Countries, Anatole Krattiger

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare (3), Atieno Ojoo

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(4), Robert Nyarango

[e-drug] Doctors prescribing heavily influenced by DTCA, E-Drug

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(5), Emeje Martins

[e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(6), Atieno Ojoo

[e-drug] Doctors prescribing heavily influenced by DTCA (2), Parrish, Richard

[e-drug] Doctors prescribing heavily influenced by DTCA (3), Dr Peter R Mansfield
[e-drug] Doctors prescribing heavily influenced by DTCA (4), Joel Lexchin

[e-drug] pharmacist v/s physician?, sushobhit singh

[e-drug] RFI: Availability of ACT?, Libby Levison

[e-drug] GPP - Good Publication Practice (for drug companies), E-Drug

Mail converted by MHonArc 2.6.8